Aug 2026· Cancer Treatment and Research Communications· Vol 49, pp.
101373
· 0 citations· 51 references
Medicine
TL;DR
Future priorities include elucidating the impact of metformin on immunotherapeutic efficacy across tumor types, optimizing combination regimens, and identifying predictive biomarkers-areas in which high-quality international collaboration will be critical.
Abstract
The convergence of metformin and cancer immunotherapy has recently gained intense global interest, driven by evidence that metformin can remodel the tumor immune microenvironment and potentiate immune-based treatments. No bibliometric study has yet mapped this rapidly expanding field. We searched the Web of Science Core Collection from January 1, 2007, to July 8, 2026, for English papers containing metformin and immunotherapy terms, retrieving 328 papers. VOSviewer 1.6.19 and CiteSpace 6.2.R4 were used to quantify publications, citations, collaboration networks (countries, institutions, and authors), keyword co-occurrence, citation bursts, and temporal trends. The compound annual growth rate (CAGR) was 26.71% per year; 93.3% of papers were published after 2018. In the mapped country network, China contributed the most publications (n = 167), whereas the United States had the highest citation count (4402) and total link strength (56). Sun Yat-sen University led institutional output (n = 12), and Heiichiro Udono was the most productive mapped author (n = 8). The Journal for ImmunoTherapy of Cancer was the leading publication source (n = 12). Research on metformin plus immunotherapy is surging. Future priorities include elucidating the impact of metformin on immunotherapeutic efficacy across tumor types, optimizing combination regimens, and identifying predictive biomarkers-areas in which high-quality international collaboration will be critical.
Pancreatic cancer remains a highly lethal malignancy with limited therapeutic options. Nanoparticle-based strategies hold great promise for improving treatment outcomes, yet the global research landscape and evolutionary trajectory remain unclear. We performed a comprehensive bibliometric analysis of publications from...
Yun-Sheng Liu, Rong-De Zhong, Fen-Yong Yao et al.· Nanomedicine: Nanotechnology...· 0 citations
This study clarifies the intellectual structure and evolution of nano-immuno-oncology and identifies three major themes: photodynamic therapy combined with immune checkpoint blockade; tumor-microenvironment remodeling and melanoma immunotherapy; and nanomaterial-mediated immune activation involving cell death, antigen...
Yan-Zhen Mai, Ya-Qin Wang, Wei-Wei Li et al.· Frontiers in Oncology· 1 citation
Objectives Cancer immunotherapy has achieved remarkable clinical success; however, therapeutic resistance remains a major challenge. Increasing evidence suggests that gut microbiota-derived metabolites play a critical role in modulating host immune responses and influencing treatment outcomes. This study aimed to syste...
Ying-Ying Hu, Chen-Huai Teng, Dian Zhang· Frontiers in Cellular and In...· 0 citations
Background: This bibliometric study aimed to map the global research landscape of immunotherapy for biliary tract cancers (BTC) from 2014 to 2023, identifying key contributors and emerging trends. Methods: We analyzed 481 English-language articles retrieved from the Web of Science Core Collection (2014–2023) using Cite...
Yan-Yan Miu, Cui-Ling Zhang, Yan Niu et al.· Medicine· 0 citations
Background The gut microbiota can alter drug metabolism, efficacy, and toxicity, while medications can reciprocally reshape microbial communities. However, the structure and maturation of research specifically addressing these bidirectional interactions have not been comprehensively mapped. Methods The Web of Science C...
Ying-Xian Dong, Long-Xi He, H. Du· Frontiers in Microbiology· 0 citations
This paper maps how JAK inhibitor research in China developed between 2017 and 2026, examining its knowledge structure, the topics that drew attention, and the directions now emerging. JAK inhibitor publications with at least one Chinese affiliation were identified in the Web of Science Core Collection between January...
Yi-Sheng Jiang· Journal of Clinical Technolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.